Dapivirine Study Reveals Best Path Forward for Future HIV Microbicide Research

In a major finding, HIV microbicide researchers have found new and encouraging evidence that the antiretroviral drug dapivirine, a nonnucleoside reverse transcriptase inhibitor (NNRTI), is not impacted by a woman's vaginal microbiome composition when administered as a vaginal gel or film.

The Body PRO